REG - First Derivatives - Statement regarding Brian Conlon

FD TechnologiesAnnouncement

17/05/2019 07:00

RNS Number : 3334Z
First Derivatives PLC
17 May 2019
 


17 May 2019
 
First Derivatives plc
("FD" or the "Group")
 
Statement regarding Brian Conlon
 
FD (AIM: FDP.L, Euronext Growth: FDP.I) announces that Brian Conlon, Chief Executive Officer, has recently been diagnosed with cancer. Brian will remain as Chief Executive Officer during his ongoing weekly treatment, which includes chemotherapy. This treatment is expected to last a number of months.
 
Seamus Keating, Chairman of FD, said: "The Board has set a clear strategy and the Executive Committee, led by Brian, has delivered strong execution of that strategy year-on-year. During the period of his treatment I will provide additional executive and governance support and I am confident that Brian and his team will continue to execute the Group's growth plans successfully."
 
Enquiries
For further information please contact:
 



First Derivatives plc
Brian Conlon, Chief Executive Officer
Graham Ferguson, Chief Financial Officer
Ian Mitchell, Head of Investor Relations


+44(0)28 3025 2242
www.firstderivatives.com




 


 




Investec Bank plc (Nominated Adviser and Broker)
Andrew Pinder
Carlton Nelson
Sebastian Lawrence


+44 (0)20 7597 5970




 


 




Goodbody (Euronext Growth Adviser and Broker)
David Kearney
Finbarr Griffin
 


+353 1 667 0420
 




 


 




FTI Consulting
Matt Dixon
Dwight Burden
Darius Alexander
Niamh Fogarty
 


+44 (0)20 3727 1000




 


 



About FD
FD is a global technology provider with 20 years of experience working with some of the world's largest finance, technology, retail, pharma, manufacturing and energy institutions. The Group's Kx technology, incorporating the kdb+ time-series database, is a leader in high-performance, in-memory computing, streaming analytics and operational intelligence. Kx delivers the best possible performance and flexibility for high-volume, data-intensive analytics and applications across multiple industries. FD operates from 14 offices across Europe, North America and Asia Pacific, including its headquarters in Newry, and employs more than 2,400 people worldwide.
 
For further information, please visit www.firstderivatives.com and www.kx.com
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRAFMFTMBABBBL